Siemens Health/€SHL
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Siemens Health
Siemens Healthineers AG, listed under the ticker SHL, operates in the healthcare sector and is particularly known for its innovative medical technology. The company, a segment of the larger Siemens Group, specializes in diagnostic and therapeutic products and services, including medical imaging, laboratory diagnostics, and point-of-care testing. Founded in 1847 as part of Siemens AG, Siemens Healthineers was spun off as a separate entity in 2018, reflecting its focus on healthcare technology and services.
Ticker
€SHL
Sector
Primary listing
XETRA
Employees
73,800
Headquarters
Website
Siemens Health Metrics
BasicAdvanced
€48B
22.85
€1.91
0.85
€0.95
2.18%
Price and volume
Market cap
€48B
Beta
0.85
52-week high
€58.48
52-week low
€41.21
Average daily volume
50K
Dividend rate
€0.95
Financial strength
Current ratio
1.115
Quick ratio
0.701
Long term debt to equity
62.694
Total debt to equity
81.82
Dividend payout ratio (TTM)
49.72%
Interest coverage (TTM)
7.44%
Profitability
EBITDA (TTM)
4,460
Gross margin (TTM)
38.63%
Net profit margin (TTM)
9.17%
Operating margin (TTM)
13.54%
Effective tax rate (TTM)
24.04%
Revenue per employee (TTM)
€320,000
Management effectiveness
Return on assets (TTM)
4.37%
Return on equity (TTM)
11.93%
Valuation
Price to earnings (TTM)
22.848
Price to revenue (TTM)
2.096
Price to book
2.66
Price to tangible book (TTM)
-8.59
Price to free cash flow (TTM)
18.05
Free cash flow yield (TTM)
5.54%
Free cash flow per share (TTM)
2.418
Dividend yield (TTM)
2.18%
Forward dividend yield
2.18%
Growth
Revenue change (TTM)
4.53%
Earnings per share change (TTM)
10.40%
3-year revenue growth (CAGR)
2.49%
10-year revenue growth (CAGR)
6.10%
3-year earnings per share growth (CAGR)
1.81%
10-year earnings per share growth (CAGR)
4.11%
3-year dividend per share growth (CAGR)
1.72%
What the Analysts think about Siemens Health
Analyst ratings (Buy, Hold, Sell) for Siemens Health stock.
Bulls say / Bears say
Siemens Healthineers posted Q3 2025 revenue of €5.66 billion, up 7.6% from the prior year, slightly exceeding analyst estimates, and raised its full-year comparable revenue growth outlook to 5.5%–6%. Free cash flow jumped 54% to €844 million (Reuters).
The company said it does not expect recent Chinese government purchase restrictions on medical devices to have a material impact, pointing to its strong local manufacturing base and global operations as buffers against regional trade friction (Reuters).
Despite tariff challenges, Siemens Healthineers raised its quarterly dividend from €0.95 to €1.00 per share, reflecting strong cash flows and management's confidence in the firm's financial position (Reuters).
Higher U.S. import tariffs are expected to cost Siemens Healthineers €200 million in 2025 and about €400 million in 2026, contributing to a slight sales miss in the fourth quarter (Reuters).
Siemens AG's preparation to potentially reduce its stake below 50% has led Siemens Healthineers to engage with credit rating agencies and review refinancing, creating uncertainty around the group's capital structure and credit metrics (Reuters).
New Chinese limits on government purchases of EU-made medical devices above 45 million yuan underscore ongoing geopolitical trade risks, raising concerns about demand in a key market (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2025.
Siemens Health Financial Performance
Revenues and expenses
Siemens Health Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Siemens Health stock?
Siemens Health (SHL) has a market cap of €48B as of November 09, 2025.
What is the P/E ratio for Siemens Health stock?
The price to earnings (P/E) ratio for Siemens Health (SHL) stock is 22.85 as of November 09, 2025.
Does Siemens Health stock pay dividends?
Yes, the Siemens Health (SHL) stock pays dividends to shareholders. As of November 09, 2025, the dividend rate is €0.95 and the yield is 2.18%. Siemens Health has a payout ratio of 49.72% on a trailing twelve-month basis.
When is the next Siemens Health dividend payment date?
The next Siemens Health (SHL) dividend payment date is unconfirmed.
What is the beta indicator for Siemens Health?
Siemens Health (SHL) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.